Long term use of oral contraceptives without thrombosis in patients with FV Leiden polymorphism: A study of 37 patients (2 Homozygous and 35 Heterozygous)

Journal of Thrombosis and Thrombolysis

Volumn 17, Issue 2, 2004, Pages 145-149

  Girolami, Antonio ^a,b   Tormene, D ^a   Gavasso, S ^a   Bertolo, C ^a   Girolami, B ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

^b Institute of Medical Semeiotics   (Italy)

Author keywords

FV Leiden polymorphism; Oral contraceptives; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CYPROTERONE; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DIANE; ECOGYN; ETHINYLESTRADIOL PLUS GESTODENE; ETHINYLESTRADIOL PLUS LEVONORGESTREL; EVANORD; FEDRA; GESTODENE; LEVONORGESTREL; ORAL CONTRACEPTIVE AGENT; PROGESTERONE DERIVATIVE; SECURGIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG CONTRAINDICATION; DRUG USE; FEMALE; FLUID RETENTION; HEADACHE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; PHLEBITIS; PREGNANCY; PRIORITY JOURNAL; SYMPTOMATOLOGY; THROMBOGENICITY; THROMBOSIS; VARICOSIS;

ADULT; CONTRACEPTIVES, ORAL; FACTOR V; FEMALE; FOLLOW-UP STUDIES; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMANS; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC; THROMBOSIS; TIME FACTORS;

EID: 4344665187     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:THRO.0000037671.98201.15     Document Type: Article

References (26)

1. Vandenbroucke JP, Rosing J, Bloemenkamp KW, et al. Oral contraceptives and the risk of venous thrombosis. N Engl J Med 2001;344:1527-1535.
2. Winkler VM. Blood coagulation and oral contraceptives. Contraception 1998;57:203-209.
3. World Health Organizzation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptves: Result of international multicentre case-control study. Lancet 1995;346:1575-1582.
4. World Health Organizzation Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. Lancet 1995;346:1582-1588
5. Helmrich SP, Rosenberg L, Kaufman DW, Strom B, Shapiro S. Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 1987;69:91-95.
6. Vessey M, Mant D, Smith A, Yates D. Oral contraceptives and venous thromboembolism: Findings in a large prospective study. Br Med J 1986 292:526-530.
7. Girolami A, Simioni P, Girolami B, Zanardi S. The role of drugs, particularly oral contraceptives, in triggering thrombosis in congenital defects of coagulation inhibitors: A study of six patients. Blood Coag Fibrin 1991;2:673-678.
8. Girolami A, Stevanato F, Lazzaro AR. Bilateral ileofemoral thrombophlebitis after ten contraceptive pills in a 25-year-old woman with antithrombin III deficiency. Acta Haematol 1988;79:118-119.
9. Girolami A, Simioni P, Sartori MT, Zanardi S. Oral contraceptives caused thrombosis in a monoclonal twin with protein C deficiency, while the other, without medication, remained asymptomatic. Blood Coag Fibrin 1992;3:119-120.
10. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-1457.
11. Girolami A, Simioni P, Girolami B, Radossi P. Homozygous patients with APC resistance may remain paucisymptomatic or asymptomatic during oral contraception. Blood Coagul Fibrinol 1996;7:590-594.
12. Girolami A, Simioni P, Zanardi S, Scarano L, Girolami B. Patients with APC resistance compared with those with other clotting inhibitor deficiences show later onset of venous thrombosis during oral contraception. Clin Appl Thrombosis / Hemostasis 1995;1:274-276.
13. Simioni P, Prandoni P, Girolami A. Low rate of venous thromboembolism in asymptomatic relatives of probants with factor V Leiden mutation. Ann Intern Med 1999;130:53-58.
14. Girolami A, Simioni P, Tormene D, Scarano L. Two additional homozygous patients for the 20210 prothrombin polymorphism with no venous thrombosis. Thromb Res 1999;96:415-417.
15. Girolami A, Tormene D, Simioni P, Zanon E. Long-term use of oral contraceptive therapy in women with the prothrombin 20210 G-A polymorphism without thrombotic complications: A study of 13 women (12 heterozygotes and 1 homozygote). Thromb Res 2001;102:205-210.
16. Simioni P, Prandoni P, Lensing AWA, et al. Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood 2000;10:3329-3333.
17. de Moerloose P, Reber G, Perrier A, Perneger T, Bounameaux H. Prevalence of factor V Leiden and prothrombin G20210A mutations in unselected patients with venous thromboembolism. Br J Haematol 2000 110:125-129.
18. Cogo A, Bernardi E, Prandoni P, et al. Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 1994 154:164-168.
19. Girolami A, Scarano L, Girolami B, Marchiori A. Emphasis on congenital conditions predisposing to thrombosis should not make us disregard the importance of acquired factors. Blood Coagul Fibrin 1998;9:659-660.
20. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B. Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
21. Weiss G. Risk of venous thromboembolism with third-generation oral contraceptives: A review. Am Obstet Gynecol 1999;180:295-301.
22. Walker AM. Newer oral contraceptives and the risk of venous thromboembolism. Contraception 1998;57:169-181.
23. Conrad J. Biological coagulation findings in third-generation oral contraceptives. Human Reprod Update 1999;5:672-680.
24. Girolami A, Spiezia L, Vianello F, Girolami B, Fabris F. Changes in prescription patterns of oral contraceptives in a Northern Italian Province: Relation with venous thromboembolism. Clin and Appl Thrombosis / Haemostasis 2003;9:125-130.
25. Rintelen C, Mannhalter C, Ireland H, et al. Oral contraceptives ehnance the risk of clinical manifestations of venous thrombosis at a young age in females homozygotes for Factor V Leiden. Brit J Med 1996;93:487-490.
26. Girolami A, Spiezia L, Vianello F. Proposal of a Flow Chart for thrombosis-free oral contraceptive therapy. Clin Appl Thrombosis / Haemost 2003;9:33-37.